Also, our western-blot results showed that the level of p-Akt (T308), p-ERK (T202/Y204), and p-p53 (S392) were all dramatically reduced upon DSD treatment in GC cells, validating the above signaling pathway enrichment result. The gene discussed is TP53; the disease is disorder of sexual differentiation.